GlassScriptPhysician profile
Irina Tartakovsky
NPI 1982685103
$819.05
in general payments reported to CMS, 2019-2025
17 companies · $271 in 2025
The $271 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $11.80 · 2023: $306 · 2024: $230 · 2025: $271.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $807.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $807.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $175.31 | 2023-2025 | Mavyret, Synthroid |
| Medtronic, INC. | $145.61 | 2024-2025 | Minimed 780g |
| Lilly USA, LLC | $107.63 | 2023 | Mounjaro |
| Takeda Pharmaceuticals U.S.A., INC. | $68.00 | 2023 | Elaprase |
| Astellas Pharma US INC | $49.19 | 2023-2024 | Veozah |
| Xeris Pharmaceuticals, INC. | $48.56 | 2024-2025 | Gvoke Hypopen, Recorlev |
| Amgen INC. | $36.02 | 2025 | Evenity, Prolia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $33.95 | 2023 | Trulance, Xifaxan |
| Insulet Corporation | $21.11 | 2023 | Omnipod |
| Janssen Biotech, INC. | $18.69 | 2025 | Tremfya |
| Mannkind Corporation | $18.33 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $18.17 | 2024 | Zoryve |
| Ucb, INC. | $17.73 | 2023 | Cimzia |
| Novo Nordisk INC | $16.81 | 2024 | |
| Ani Pharmaceuticals, INC. | $16.07 | 2024 | Purified Cortrophin Gel |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $16.07 | 2024 | Arcalyst |
| Allergan, INC. | $11.80 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Irina Tartakovsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.